Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A F Lever

Showing results (11-20 of 278) with videos related to

Pageof 28
Sort By:
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|November 1, 1993
MRC trial of treatment in elderly hypertensivesA F Lever, P J Brennan
Clinical and Experimental Pharmacology & Physiology|February 1, 1994
Effect of sex-related changes in blood pressure at entry to the MRC trial on prediction of cardiovascular riskJ A Millar, A F Lever
Histopathology|April 1, 1986
Anatomy of the renin-angiotensin system in the normal and pathological kidneyG B Lindop, A F Lever
Journal of Cardiovascular Pharmacology|January 1, 1990
Blood pressure, change in blood pressure, and cardiovascular event rates in placebo-treated patients in the Medical Research Council TrialJ A Millar, A F Lever
Hypertension (Dallas, Tex. : 1979)|November 18, 2000
Implications of pulse pressure as a predictor of cardiac risk in patients with hypertensionJ A Millar, A F Lever
British Medical Journal (Clinical Research Ed.)|October 11, 1986
Glimpses of the mechanisms of hypertensionP F Semple, A F Lever
Journal of Hypertension|August 23, 2000
Excess mortality associated with increased pulse pressure among middle-aged men and women is explained by high systolic blood pressureJ A Millar, A F Lever
Journal of Human Hypertension|June 1, 1995
Adjustment of the apparent benefits of treatment on stroke risk in the MRC mild hypertension trial using data from the placebo-treated groupJ A Millar, A F Lever
Journal of Hypertension|February 1, 1992
Essential hypertension: a disorder of growth with origins in childhood?A F Lever, S B Harrap
Journal of Hypertension|August 1, 1988
Vasovagal reactions to cardiovascular drugs: the first dose effectP F Semple, P Thorén, A F Lever
Pageof 28

Showing results (11-20 of 278) with videos related to

Sort By:
Pageof 28
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|November 1, 1993
MRC trial of treatment in elderly hypertensivesA F Lever, P J Brennan
Clinical and Experimental Pharmacology & Physiology|February 1, 1994
Effect of sex-related changes in blood pressure at entry to the MRC trial on prediction of cardiovascular riskJ A Millar, A F Lever
Histopathology|April 1, 1986
Anatomy of the renin-angiotensin system in the normal and pathological kidneyG B Lindop, A F Lever
Journal of Cardiovascular Pharmacology|January 1, 1990
Blood pressure, change in blood pressure, and cardiovascular event rates in placebo-treated patients in the Medical Research Council TrialJ A Millar, A F Lever
Hypertension (Dallas, Tex. : 1979)|November 18, 2000
Implications of pulse pressure as a predictor of cardiac risk in patients with hypertensionJ A Millar, A F Lever
British Medical Journal (Clinical Research Ed.)|October 11, 1986
Glimpses of the mechanisms of hypertensionP F Semple, A F Lever
Journal of Hypertension|August 23, 2000
Excess mortality associated with increased pulse pressure among middle-aged men and women is explained by high systolic blood pressureJ A Millar, A F Lever
Journal of Human Hypertension|June 1, 1995
Adjustment of the apparent benefits of treatment on stroke risk in the MRC mild hypertension trial using data from the placebo-treated groupJ A Millar, A F Lever
Journal of Hypertension|February 1, 1992
Essential hypertension: a disorder of growth with origins in childhood?A F Lever, S B Harrap
Journal of Hypertension|August 1, 1988
Vasovagal reactions to cardiovascular drugs: the first dose effectP F Semple, P Thorén, A F Lever
Pageof 28